May 28, 2016 10:52 PM ET

Capital Markets

Company Overview of Deerfield Management Company, L.P.

Company Overview

Deerfield Management Company, L.P. is an employee owned hedge fund sponsor. The firm primarily provides its services to pooled investment vehicles. It invests in public equity markets of the United States. The firm makes its private equity investments in large cap and growth companies. It typically invests in healthcare sector which includes pharmaceuticals, biotechnology, generic drugs, over the counter drugs, medical devices, medical equipments, diagnostics, hospital supplies, hospital services, acute care hospitals, nursing homes, psychiatric hospitals, alternate site providers, home care, physician practice management, medical software HMOs, health insurers, benefit management companies,...

780 Third Avenue

37th Floor

New York, NY 10017

United States

Founded in 1994





Key Executives for Deerfield Management Company, L.P.

Age: 49
Age: 54
Partner and Trader
Chief Financial Officer
Age: 48
Compensation as of Fiscal Year 2015.

Deerfield Management Company, L.P. Key Developments

Deerfield Management Company, L.P. Appoints Gregory Sorensen as Executive Chairman

Deerfield Management Company, L.P. announced that it has created a partnership with Gregory Sorensen, M.D., and Deerfield Imaging (IMRIS). Dr. Sorensen will take a significant minority interest in Deerfield Imaging and will become the Executive Chairman. Dr. Sorensen served until recently as President and CEO of Siemens Healthcare North America, and is a neuroradiologist well known in the industry for his innovative research in medical imaging and for his expertise in clinical practice. In his role as Executive Chairman of the company, Sorensen will provide both strategic and operational guidance, drawing on his clinical and business experience in image-guided surgery and neuro radiology.

Deerfield Management Company, L.P. Presents at Emerging Medical Technologies Summit, Oct-20-2015 08:05 AM

Deerfield Management Company, L.P. Presents at Emerging Medical Technologies Summit, Oct-20-2015 08:05 AM. Venue: Sofitel Hotel San Francisco, 223 Twin Dolphin Dr., Redwood City, CA 94065, United States. Speakers: Steven Hochberg.

DepoMed Seeks Acquisitions

Deerfield Management Company, L.P. announced a $375 million debt investment in DepoMed Inc. (NasdaqGS:DEPO) as part of $575 million facility to support Depomed's $1.1 billion acquisition of NUCYNTA. "The acquisition of NUCYNTA is transformational for Depomed. Our facility has been structured to avoid equity dilution and provide flexible terms for repayment and future acquisitions." said Alex Karnal, Partner at Deerfield Management.

Similar Private Companies By Industry

Company Name Region
@Visory LLC United States
1 Road Partners LLC United States
11T Partners, LLC United States
13D Research (USVI) LLC. United States
1509225 Ontario, Inc. United States

Recent Private Companies Transactions

Private Placement
May 11, 2016
Neos Therapeutics, Inc.
Private Placement
May 2, 2016
Homology Medicines, Inc.
Private Placement
April 29, 2016
Graybug Vision, Inc.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Deerfield Management Company, L.P., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at